P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Partnerships for Accelerating Cancer Therapies (PACT)
|
Other
|
FDA
|
NCI, OD/ OSP
|
2016
|
|
Pathogen Detection Project
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Pertussis Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2012
|
|
PhenX Tobacco Regulatory Research (TRR) Working Groups
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ DPCPSI/ ODP
|
Unknown
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Preparing for the Next Outbreak of Ebola Virus Infection: Working Group Meeting
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2016
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children
|
Committee, Advisory Group, or Work Group
|
FDA, OSG
|
NCI, NHLBI, NIAID, NICHD, NIEHS
|
1997
|
|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIAID
|
2015
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|